CoChat

Stimulants for depression: On the up and up?

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

The use of traditional psychostimulants (methylphenidate and dexamphetamine) and stimulant-like drugs (modafinil and armodafinil) for the treatment of depression is a growing concern given the lack of research evidence supporting their effectiveness. The current article describes the role of stimulants in treating depression--specifically their risks and benefits and their potential use alongside antidepressants. Clinically, the rapid amelioration of depressive symptoms with traditional psychostimulants is often dramatic but short-lived, and this suggests that they likely operate via different mechanisms to conventional antidepressants. More importantly, there is little evidence from randomised controlled trials supporting their efficacy in treating depression, although modafinil has been shown to be effective in reducing prominent depressive symptoms, such as fatigue. Research is urgently required to clarify psychostimulants' mechanisms of action and to evaluate their long-term benefits and risks in the treatment of major and bipolar depression. Ultimately, specificity of action needs to be determined to inform the sophisticated clinical use of psychostimulants in the management of depression. Until then they should only be prescribed if absolutely necessary, and even then their prescription should be facilitatory and time limited unless it is for investigational purposes.

Overview

Integrity signals

Registry

Crossref · 10.1177/0004867416634208

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 25 references

Cited by

See all 46

Metadata

Authors
Malhi, G. S., Byrow, Y., Bassett, D., Boyce, P., Hopwood, M., Lyndon, W., Mulder, R., Porter, R., Singh, A., & Murray, G.
Affiliations
  • The University of Sydney (AU)
  • Royal North Shore Hospital (AU)
  • The University of Western Australia (AU)
  • The University of Melbourne (AU)
  • University of Otago (NZ)
  • Deakin University (AU)
  • Swinburne University of Technology (AU)
Corresponding author
Malhi, Gin S
Venue
Australian & New Zealand Journal of Psychiatry
Published
2016-02-23
Volume
50
Issue
3
Pages
203-207
ISSN
  • 0004-8674 (ISSN-L)
  • 1440-1614
OpenAlex
W2312263068
Cited by
46
References
0
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 9 · 2021: 6 · 2020: 7 · 2019: 4 · 2018: 5 · 2017: 6 · 2016: 3
FWCI
5.13
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Australian & New Zealand Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
  • Figshare (submittedVersion)
  • Swinburne figshare (Swinburne University of Technology) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords
psychostimulants, depression, methylphenidate, d-amphetamine, modafinil, armodafinil, antidepressant augmentation, major depressive disorder, bipolar depression, fatigue, mechanism of action, efficacy evidence, benefits and risks, drug prescribing
MeSH terms
Modafinil, Amphetamine, Central Nervous System Stimulants, Antidepressive Agents, Benzhydryl Compounds, Bipolar Disorder, Depression, Depressive Disorder, Major, Major Depressive Disorder, Dextroamphetamine, Drug Therapy, Combination, Humans, Methylphenidate, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stimulants for depression: On the up and up? https://app.cochat.ai/papers/10.1177/0004867416634208
The paper
Malhi, G. S., Byrow, Y., Bassett, D., Boyce, P., Hopwood, M., Lyndon, W., Mulder, R., Porter, R., Singh, A., & Murray, G. (2016). Stimulants for depression: On the up and up? Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867416634208

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.